Erschienen in:
01.12.2012 | Case Report
Advanced diffuse malignant peritoneal mesothelioma responding to palliative chemotherapy
verfasst von:
Koji Nakashima, Haruhiko Inatsu, Kazuo Kitamura, Tomomi Hikosaka, Shinri Hoshiko, Shinya Ashiduka
Erschienen in:
Clinical Journal of Gastroenterology
|
Ausgabe 6/2012
Einloggen, um Zugang zu erhalten
Abstract
A 64-year-old man diagnosed with advanced malignant peritoneal mesothelioma by laparoscopic biopsy was treated with systemic chemotherapy. The patient underwent first-line chemotherapy with pemetrexed plus cisplatin for 11 months, then second-line chemotherapy with gemcitabine plus vinorelbine for 6 months, and third-line chemotherapy with CPT-11 for 4 months. After third-line chemotherapy failed, he received palliative treatment. Although the tumor continued to grow, and he died 24 months after initiation of treatment, chemotherapy prolonged the survival time and improved his quality of life.